Literature DB >> 7035639

Carnitine blood concentrations and fat utilization in parenterally alimented premature newborn infants.

E Schmidt-Sommerfeld, D Penn, H Wolf.   

Abstract

To investigate the relationships among carnitine intake, carnitine blood concentrations, and the ability to utilize exogenous fat, total carnitine, free carnitine, acylcarnitine, beta-hydroxybutyrate, free fatty acid and triglyceride plasma concentrations were measured in 26 parenterally alimented appropriate-for-gestational-age premature infants before and at the end of a four-hour infusion of Intralipid, 1 gm/kg body weight. There was an increase in plasma levels of AC, BOB, FFA, and TG, but a decrease of FC, TC was unaffected by the infusion, but strongly correlated with calculated carnitine intake. At the end of the fat infusion, AC and BOB were positively correlated, and FFA negatively correlated with TC. The results demonstrate the proportion of AC to FC to be an additional indicator of fatty acid utilization and suggest that decreased carnitine intake in premature infants may impair fatty acid oxidation and ketogenesis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7035639     DOI: 10.1016/s0022-3476(82)80652-5

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  3 in total

1.  Randomised controlled trial of an aggressive nutritional regimen in sick very low birthweight infants.

Authors:  D C Wilson; P Cairns; H L Halliday; M Reid; G McClure; J A Dodge
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-07       Impact factor: 5.747

2.  Pharmacokinetic analysis of azelaic acid disodium salt. A proposed substrate for total parenteral nutrition.

Authors:  A Bertuzzi; A Gandolfi; S Salinari; G Mingrone; E Arcieri-Mastromattei; E Finotti; A V Greco
Journal:  Clin Pharmacokinet       Date:  1991-05       Impact factor: 6.447

Review 3.  Normal vitamin requirements in neonates and infants.

Authors:  C J Bates
Journal:  J Inherit Metab Dis       Date:  1985       Impact factor: 4.982

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.